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Inflammatory and degenerative condi-
tions affecting the musculoskeletal sys-
tem rank among the most frequently oc-
curring, chronic conditions. They are 
subsumed under the term musculoskel-
etal condition (MSKC). MSKC affect the 
majority of the older and aged popula-
tion and are worldwide the leading cause 
of chronic pain, physical impairment and 
decrease in quality of life [1, 2, 3].
According to estimates by the World 
Health Organisation (WHO) the num-
ber of persons affected by a bone or joint 
condition will double between the year 
2000 and 2020 [4]. Consequently, many 
efforts are being made internationally to 
effectively deal with musculoskeletal con-
ditions and the burden of associated dis-
eases. To this end, the WHO for exam-
ple launched the Bone and Joint Decade 
2000–2010 in order to improve the re-
search and care situation.
In Germany, MSKC rank among the 
most frequent health conditions [5]. They 
cause high economic costs through ex-
penses incurred for illness-specific treat-
ments and as a consequence of incapacity 
for work and forced early retirement [6, 7].
Population-representative data on 
the prevalence of MSKC in Germany are 
largely disease-specific and mostly based 
on surveys in small areas or claims data 
and other routine data [7, 8, 9, 10, 11, 12, 
13, 14, 15, 16, 17]. MSKC comprise degen-
erative joint disorders (e.g. osteoarthri-
tis), inflammatory joint disorders (e.g. 
rheumatoid arthritis) and skeletal disor-
ders (e.g. osteoporosis). The present pa-
per describes the current distribution of 
the three aforementioned conditions in 
the German population.
Osteoarthritis
Worldwide, osteoarthritis is the most fre-
quently occurring joint disorder [4, 18] 
and causes more limitations and disabili-
ties in the older population than any oth-
er disease [3]. Osteoarthritis is character-
ized by degenerative changes in the joints. 
These start with the successive loss of ar-
ticular cartilage and may even lead to 
the exposure of the bone surface. Dam-
age to neighbouring structures such as 
bone, muscles and ligaments are also fre-
quently observed. Osteoarthritis can be 
diagnosed through pathological chang-
es in the X-ray image but also via joint 
complaints. Immutable risk factors are 
increasing age, female sex and genetic 
pre-disposition [19, 20, 21]. In addition 
there are acquired causes or contributo-
ry causes such as overloading or inappro-
priate straining of the joints due to con-
genital deformities (e.g. axial misalign-
ment, hip dysplasia), following injuries 
and accidents or by being overweight 
[22].
Rheumatoid arthritis (RA)
The term arthritis is used to group chron-
ic inflammatory, systemic joint disorders 
which occur on the basis of auto-immune 
processes that have not been completely 
clarified yet. The most important risk fac-
tors for these chronic inflammatory joint 
disorders are female sex, high age, envi-
ronmental factors such as smoking and 
a multitude of genetic factors [23, 24, 25].
Inflammatory joint disorders proceed 
mostly in stages and progressively. They 
often involve chronic functional impair-
ment accompanied by pain and reduced 
quality of life. The most frequent inflam-
matory joint condition is rheumatoid ar-
thritis (RA) [3, 26]. RA is characterised 
clinically by swelling of the joints and 
pain and leads to erosive destruction of 
the joints and functional impairment [27]. 
Diagnosis is based on classification crite-
ria which were updated in 2010 with the 
aim of improved early diagnosis and treat-
ment [28]. The criteria refer to the num-
ber of joints affected, serology, inflamma-
tion markers and the duration of symp-
toms.
Osteoporosis
Osteoporosis is a systemic skeletal disor-
der which is characterised by low bone 
mass and microarchitectural deteriora-
tion of bone tissue [29], which increases 
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bone fragility [30]. This leads to a higher 
susceptibility to fractures even in minor 
external events (fragility fractures). Typi-
cal areas for fragility fractures are primar-
ily the vertebral body, sections close to 
the femur (femoral neck and the region 
of trochanter) as well as the section of the 
radius close to the wrist (distal radius).
A multitude of factors contribute to the 
development of osteoporosis. These in-
clude non-modifiable factors such as in-
creasing age, female sex and family pre-
disposition, as well as underlying condi-
tions and medication, which can be treat-
ed causally or adapted, and behavioural 
risk factors that can be modified such as 
lack of exercise or malnutrition [29].
Osteoporosis is highly relevant for 
health policy due to the close link with 
older age and the consequences of frac-
tures. Hip and vertebral fractures in par-
ticular, lead to reduced quality of life and 
losses in independent living. Since hip 
fractures in contrast to vertebral fractures 
are always diagnosed and treated opera-
tively, they cause the highest direct treat-
ment costs [31, 32].
Methods
Study design and sample
The German Health Interview and Ex-
amination Survey for Adults (“Studie zur 
Gesundheit Erwachsener in Deutsch-
land”, DEGS) is part of the health mon-
itoring system of the Robert Koch In-
stitute (RKI). The concept and design 
of DEGS are described in detail else-
where [33, 34, 35, 36, 37]. The first wave 
(DEGS1) was conducted from 2008–2011 
and comprised interviews, examinations 
and tests [38, 39]. The target population 
comprises the residents of Germany aged 
18–79 years. DEGS1 has a mixed design 
which permits both cross-sectional and 
longitudinal analyses. For this purpose, 
a random sample from the local popu-
lation registries was drawn to complete 
participants of the German National 
Health Interview and Examination Sur-
vey 1998 (GNHIES98), who re-partic-
ipated. A total of 8,152 persons partici-
pated, including 4,193 first-time partic-
ipants (response rate 42%) and 3,959 re-
visiting participants of GNHIES98 (re-
sponse rate 62%). 
There were 7,238 persons who attend-
ed one of the 180 examination centres, 
and 914 were interviewed only. The net 
sample (n=7,988) permits representative 
cross-sectional and time trend analyses 
for the age range of 18–79 years in com-
parison with GNHIES98 [34]. The da-
ta of the revisiting participants can be 
used for longitudinal analyses. A non-
Tab. 1 Lifetime prevalence of osteoarthritis by sex, age group and social status
    Age group (years) Osteoarthritis, un-
weighted case numbers
    18–29 (%) 30–39 (%) 40–49 (%) 50–59 (%) 60–69 (%) 70–79 (%) Overall (%) Yes No
Women
Social status Low 0.7 3.7 8.7 31.1 49.0 46.3 24.1 170 440
95% CI 0.1–4.6 1.2–11.2 4.7–15.8 21.3–42.9 38.9–59.3 36.7–56.1 20.4–28.3   
Middle 2.0 3.6 14.1 29.9 47.3 49.5 22.7 637 1814
95% CI 0.8–4.6 1.7–7.1 10.6–18.5 25.4–34.7 41.8–52.9 43.0–56.1 20.6–24.9   
High 1.8 3.7 10.5 29.1 42.2 67.7 19.0 211 660
95% CI 0.4–7.0 1.8–7.2 6.4–17.0 22.1–37.2 32.8–52.3 54.3–78.7 16.3–22.0   
 Overall 1.6 3.7 12.6 29.9 46.9 49.9 22.3 1018 2914
(95% 
CI)
0.8–3.2 2.3–6.1 10.1–15.7 26.6–33.5 42.6–51.2 45.2–54.5 20.8–23.8   
Men
Social status Low 5.5 4.5 17.0 32.0 34.7 24.7 18.7 117 434
95% CI 2.4–12.3 1.1–16.2 10.0–27.5 23.3–42.3 23.8–47.6 16.2–35.8 15.1–22.9   
Middle 0.5 10.8 14.3 28.9 33.5 36.6 18.6 411 1611
95% CI 0.1–2.0 6.7–17.1 10.7–18.9 23.8–34.5 27.9–39.7 30.4–43.3 16.6–20.7   
High 1.8 11.0 9.0 20.7 33.0 33.8 16.6 187 802
95% CI 0.3–11.7 5.8–20.1 5.5–14.3 14.2–29.1 25.6–41.3 24.8–44.2 13.7–19.9   
 Overall 1.8 9.6 13.2 27.5 33.8 33.3 18.1 715 2847
95% CI 0.9–3.5 6.4–14.0 10.5–16.4 23.9–31.5 29.5–38.4 28.8–38.2 16.6–19.7   
Overall
Social status Low 3.0 4.2 13.2 31.6 42.5 38.7 21.5 287 874
95% CI 1.4–6.5 1.6–10.4 8.8–19.4 25.0–39.0 35.1–50.2 31.0–47.0 18.7–24.5   
Middle 1.2 7.1 14.2 29.4 41.1 43.6 20.7 1048 3425
95% CI 0.6–2.5 4.7–10.6 11.7–17.2 26.0–33.1 36.9–45.4 39.0–48.3 19.3–22.2   
High 1.8 7.6 9.7 24.8 36.4 45.8 17.6 398 1462
95% CI 0.5–5.9 4.6–12.2 6.7–13.6 20.1–30.2 30.3–43.0 37.2–54.7 15.6–19.9   
 Overall 1.7 6.7 12.9 28.7 40.4 42.4 20.2 1733 5761
 95% CI 1.0–2.7 4.9–9.2 11.1–15.0 26.3–31.3 37.4–43.6 38.8–45.9 19.2–21.2   
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response-analysis and a comparison of 
selected indicators with data from cen-
sus statistics indicate a high level of rep-
resentativity of the net sample for the res-
idential population in Germany [34].
Variables
The analyses of lifetime prevalence for os-
teoarthritis, RA and osteoporosis were 
based on self-report of physician-diag-
nosed conditions as part of a computer-
aided interview administered by a specif-
ically trained physician. Because of the 
known, very low prevalence for osteopo-
rosis among younger and middle-aged 
adults, only participants aged 50 years 
and older were asked about osteoporosis.
The participants were asked wheth-
er they had ever been diagnosed by a 
doctor of having the respective condi-
tion and if yes, when this diagnosis took 
place, by what type of doctor (GP, spe-
cialist), whether they currently receive 
any treatment, and the kind of treatment 
(for example, medication or physiothera-
py). In the case of queries the physician 
gave standardised information on the in-
dividual conditions. For example, with re-
gard to RA the physician explained that 
RA is a serious inflammatory joint disor-
der, mostly occurring on both sides and 
almost always affecting the finger joints. 
People who indicated a physician-diag-
nosed osteoarthritis were asked to indi-
cate in which joint or joints the osteoar-
thritis is located.
In cross-sectional analyses the lifetime 
prevalence for all three conditions are re-
ported overall, and by age, sex, and socio-
economic status.
Socioeconomic status (SES) was deter-
mined using an index which includes in-
formation on school education and voca-
tional training, professional status and net 
household income (weighted by house-
hold needs) and which enables a classi-
fication into low, middle and high status 
groups [40].
Statistical analysis
The results concerning the individual 
MSKCs were calculated with 95% con-
fidence intervals (95% CI) according 
to sex, age group and SES. Participants 
with missing data were excluded from 
the analyses.
The cross-sectional analyses in DEGS1 
are conducted with a weighting factor, 
which corrects deviations in the sam-
ple from population structure (as of 
31 Dec 2010) with regard to age, sex, re-
gion and nationality, as well as commu-
nity type and education [34]. A separate 
weighting factor was prepared for the ex-
amination part. Calculating of the weight-
ing factor also considered re-participation 
probability of GNHIES98 participants, 
based on a logistic regression model.
Considering the weighting factor as 
well as the correlation of the participants 
within a community, the confidence in-
tervals were determined with the sur-
vey procedures for complex samples in 
SPSS-20. Differences are regarded as sta-
tistically significant if the respective 95% 
confidence intervals do not overlap or if 
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Prevalence of selected musculoskeletal conditions in Germany.  
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Abstract
The term musculoskeletal condition (MSKC) 
comprises inflammatory and degenerative 
diseases of joints and bones. They are among 
the most common conditions in older age 
and cause of severe long-term pain, physical 
disability, and decrease in quality of life. Da-
ta from the German Health Interview and Ex-
amination Survey for Adults (DEGS1) were 
used to estimate the life-time prevalence of 
osteoarthritis, rheumatoid arthritis (RA) and 
osteoporosis in Germany. A total of 7,988 
persons aged 18–79 years (osteoporosis 50–
79 years) were asked to report doctor-diag-
nosed MSKC in face-to-face interviews. Wom-
en were more likely to report all MSKC and all 
prevalences increase with age. Osteoarthritis 
is reported by 22.3% of women and 18.1% of 
men, RA by 3.2% of women and 1.9% of men, 
and osteoporosis by 13.1% of women and 
3.2% of men. MSKC are of great relevance for 
older adults in Germany. Data from DEGS1 
provide a lot of information along to MSKC 
and hereby allow a closer description of the 
health situation of older adults.
Keywords
Prevalence · Osteoarthritis · Rheumatoid  
arthritis · Osteoporosis · Health survey
Prävalenz ausgewählter muskuloskelettaler Erkrankungen.  
Ergebnisse der Studie zur Gesundheit 
Erwachsener in Deutschland (DEGS1)
Zusammenfassung
Der Begriff muskuloskelettale Erkrankungen 
(MSKE) umfasst unter anderen entzündliche 
und degenerative Erkrankungen des Bewe-
gungsapparats. MSKE sind weltweit häufig 
bei Älteren und stellen die führende Ursa-
che von chronischen Schmerzen, körperli-
chen Funktionseinschränkungen und Ver-
lust an Lebensqualität dar. In der Studie zur 
Gesundheit Erwachsener in Deutschland 
(DEGS1) wird die aktuelle Verbreitung der 
häufigsten MSKE Arthrose, rheumatoide Ar-
thritis (RA) und Osteoporose in Deutschland 
erfasst. Die Auswertungen basieren auf den 
Angaben von 7988 Personen im Alter von 18 
bis 79 Jahren (Osteoporose ab 50 Jahren), die 
in einem persönlichen Interview an gaben, 
ob die jeweilige Erkrankung bei ihnen jemals 
ärztlich diagnostiziert wurde. Arthrose liegt 
bei 22,3% der Frauen und 18,1% der Män-
ner vor, RA bei 3,2% der Frauen und 1,9% 
der Männer. 13,1% der Frauen und 3,2% der 
Männer geben eine Osteoporose an. Bei al-
len MSKE sind Frauen signifikant häufiger 
betroffen als Männer. Die Schätzungen für 
beide Geschlechter steigen mit zunehmen-
dem Alter an. MSKE spielen daher für die äl-
tere und alte Bevölkerung in Deutschland 
eine bedeutende Rolle. DEGS1 bietet eine 
Vielfalt von Möglichkeiten, MSKE in Zusam-
menhang mit relevanten Einflussgrößen zu 
setzen und somit den Gesundheitszustand 
der zu Hause lebenden Bevölkerung präzise 
zu be schreiben.
Schlüsselwörter
Prävalenz · Arthrose · Rheumatoide Arthritis · 
Osteoporose · Gesundheitssurvey
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An overview of the results for lifetime 
prevalence of osteoarthritis by sex, age 
group and SES can be found in . Tab. 1. 
Of all participants aged 18–79 years, 
20.2% indicate that they ever had a phy-
sician-diagnosed osteoarthritis. Women 
are significantly more often affected by 
osteoarthritis (22.3%) than men (18.1%). 
The percentage of people that report hav-
ing a physician-diagnosed osteoarthri-
tis increases significantly with age both 
in women and in men. Among 18- to 
29-year-old women, 1.6% report osteo-
arthritis, whilst among 70- to 79-year-
old women it is 49.9%. Among men, the 
prevalence in these respective age groups 
increases from 1.8 to 33.3%.
The prevalence of osteoarthritis is nei-
ther associated with SES nor with the size 
of the municipality (rural, small town, 
medium town or large town). Among 
men, however, there are regional influ-
ences: in the North Rhine-Westphalia 
and eastern regions (new federal states 
and Berlin) fewer men reported osteoar-
thritis than in the southern regions (Ba-
varia, Baden-Wuerttemberg) and north-
west/central (Schleswig-Holstein, Bremen, 
Hamburg, Lower Saxony, Hesse, Rhine-
land Palatinate, Saarland).
Common sites of osteoarthritis are 
shown in . Fig. 1. In both sexes the knee 
is affected among more than half of the 
participants, and approximately one quar-
ter reports osteoarthritis of the hip. Sig-
nificantly more women than men report 
osteoarthritis in the finger joints (36.6% 
versus 15.7%). In addition, half of the peo-
ple with osteoarthritis report osteoarthri-
tis in other joints with no further locali-
sation details.
Rheumatoid arthritis (RA)
Estimates of the prevalence of lifetime RA 
by sex, age group and SES are present-
ed in . Tab. 2. A physician-diagnosed 
RA is reported by 2.5% of all 18–79 year 
olds. Women report significantly more of-
ten RA (3.2%) than men (1.9%). The per-
centage of persons with RA increases sig-
nificantly in both sexes with age. In the 
youngest age group the prevalence is low 
at 1.7% among women and 0.5% in men. It 
increases steadily until the age group 60–
69 years in both sexes, with women re-
porting a higher prevalence (4.9%) than 
men (2.9%). In the highest age group of 
70–79 years olds there is an unchanged 
Tab. 2 Lifetime prevalence of RA by sex, age group and social status
    Age group (years)   RA, unweighted case 
numbers
    18–29 (%) 30–39 (%) 40–49 (%) 50–59 (%) 60–69 (%) 70–79 (%) Overall (%) Yes No
Women
Social status Low 2.5  8.6 6.9 9.1 5.3 5.5 33 614
95% CI 0.6–9.9  3.3–20.5 3.0–14.9 4.4–18.0 2.6–10.2 3.6–8.4   
Middle 1.8 1.1 1.7 4.1 3.6 4.5 2.7 78 2450
95% CI 0.8–4.1 0.3–3.9 0.8–3.5 2.5–6.8 2.2–5.9 2.8–7.2 2.1–3.5   
High   1.6 3.2 4.0 4.1 1.8 22 862
95% CI   0.5–5.4 1.5–6.5 1.7–8.8 1.5–10.3 1.1–2.9   
 Overall 1.7 0.6 2.9 4.6 4.9 4.9 3.2 133 3926
95% CI 0.8–3.5 0.2–2.3 1.7–5.0 3.2–6.7 3.3–7.3 3.4–6.9 2.6–4.0   
Men
Social status Low 1.9 4.2 3.2 2.4 2.1 12.5 4.0 24 562
95% CI 0.3–12.2 0.7–20.3 0.7–12.8 0.6–8.8 0.8–5.9 5.4–26.4 2.3–6.8   
Middle  0.5 0.5 1.7 2.8 4.1 1.3 32 2064
95% CI  0.1–2.4 0.1–1.5 0.7–4.0 1.6–4.9 1.9–8.7 0.9–1.9   
High 0.5  0.6 1.9 3.7 2.0 1.3 15 1001
95% CI 0.1–3.5  0.2–2.1 0.6–5.9 1.1–11.6 0.5–7.3 0.7–2.5   
 Overall 0.5 1.0 0.9 2.0 2.9 5.8 1.9 71 3627
(95% CI) 0.1–2.6 0.3–3.4 0.4–2.4 1.1–3.6 1.8–4.7 3.4–9.6 1.4–2.5   
Overall
Social status Low 2.2 2.4 5.7 4.4 6.0 7.8 4.8 57 1176
95% CI 0.7–6.8 0.4–12.5 2.6–12.1 2.2–8.6 3.2–11.1 4.5–13.3 3.4–6.6   
Middle 0.8 0.8 1.1 2.9 3.2 4.3 2.0 110 4514
95% CI 0.4–2.0 0.3–2.2 0.6–2.1 1.8–4.6 2.3–4.6 2.8–6.5 1.6–2.6   
High 0.3  1.0 2.5 3.8 2.8 1.5 37 1863
95% CI 0.0–1.8  0.4–2.6 1.4–4.6 1.7–8.1 1.2–6.0 1.0–2.4   
 Overall 1.1 0.8 1.9 3.3 3.9 5.3 2.5 204 7553




prevalence among women of 4.9% yet in 
men it increases to 5.8%.
Persons of low SES report the existence 
of RA significantly more often than peo-
ple of middle to high social status. The 
lifetime prevalence of RA is neither in-
fluenced by region nor by size of munic-
ipality.
Osteoporosis
An overview of the results for lifetime 
prevalence of osteoporosis for partici-
pants aged 50 years and older by sex, age 
group and SES can be found in . Tab. 3; 
8.5% of all participants between 50 and 
79 years old report that they ever had 
a physician-diagnosed osteoporosis. 
Women report more frequently osteopo-
rosis (13.1%) than men (3.2%). In wom-
en the lifetime prevalence increases sig-
nificantly from 4.1% in the age group 50–
59 years to 25.2% among the age group 
70–79 years. Among men there is no 
such significant increase. Only among 
women is there an association of osteo-
porosis with SES: women of low SES re-
port higher rates of osteoporosis (18.5%) 
than women of middle (12.0%) and high-
er SES (8.4%).
Neither among women nor men re-
gion or size of municipality shows an as-
sociation with lifetime prevalence of os-
teoporosis.
In comparison with the results of GN-
HIES98 among men the prevalence of os-
teoporosis in the age group 50–64 years 
has not changed. There is a slight in-
crease in prevalence among men in 
the age group 65–79 years, but preva-
lence rates are low (between 3 and 4%). 
Among women there has been a decrease 
in the age group 50–64 years from 10.4 to 
6.0%. In contrast, in the age group 65–
79 years the percentage has risen from 
20.4 to 23.3%.
Prevalence of concurrent MSKCs
There were 33.9% of men and 50.1% of 
women between 50 and 79 years of age 
reporting at least one of the three MSKCs 
mentioned. . Fig. 2 shows to what extent 
the participants aged 50 years and older 
are affected by dual or multiple conditions.
Osteoarthritis combined with one of 
the two other conditions is found in a to-
tal of 8.2% of women and 3.4% of men. 
Of those people who reported RA, half 
report that they are also simultaneously 
suffering from osteoarthritis. Half of the 
women and two thirds of the men affected 
by osteoporosis also report that they suf-
fer from osteoarthritis. Less than 1% of the 
participants report a simultaneous occur-
rence of all three conditions.
If only those persons reporting osteo-
porosis are examined, there is a clear asso-
ciation with RA among this group of peo-
ple (data not shown).
Discussion
The results of DEGS1 show that osteo-
arthritis, RA and osteoporosis are fre-
quent among older people and preva-
lences differ between men and women. 
Nevertheless there are a couple of lim-
itations when prevalence estimates are 
compared. First different terminology is 
used in English and German. For exam-
ple, the term “arthritis” in English is a ge-
neric term for all joint disorders (osteo-
arthritis, RA, gout, systemic lupus ery-
thematosus fibromyalgia, or other joint 
complaints) and includes both degener-
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Fig. 2 8 Prevalence estimation regarding simultaneous occurrence of osteoarthritis, rheumatoid 
 arthritis (RA) and osteoporosis for people aged 50 years and older by sex, n=4,240
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ative (“osteoarthritis”) as well as inflam-
matory disorders. In German, “Arthri-
tis” is commonly used for inflammato-
ry joint disorders only. A comparison of 
estimates on “arthritis” has to be done 
carefully, because estimates might result 
from different conditions.
When comparing the prevalence esti-
mates of MSKC from DEGS1 with those 
of other studies, is must be taken into ac-
count that direct comparisons are diffi-
cult due to differences in age group and 
range, inclusion and diagnosis criteria. 
For example, there are considerable vari-
ations in prevalence estimates on osteo-
arthritis between self-reported or symp-
tomatic reports or on x-ray findings. For 
reasons of comparability in the following 
primarily estimates of prevalence based 
on self-reported physician diagnosis are 
used. By referring to physician-diagno-
sis it is guaranteed that we are not deal-
ing with pure self-assessments of MSKC 
and so, for example, joint complaints that 
have not been diagnosed by a doctor are 
not included. However, studies that are 
based on clinical or radiological diagno-
sis criteria in part show differing results. 
The differences are discussed in the re-
spective chapters.
Because of the differences in question 
formulation for osteoarthritis1 and arthri-
1   GNHIES98: Joint wear, osteoarthritis of the 
hip or knee joints and/or the spine; DEGS1: 
Osteoarthritis or degenerative joint disorder.
tis2 in GNHIES98 and DEGS1, trend ana-
lyses are not possible for these two con-
ditions. The medical interview in GN-
HIES98 included a broad spectrum of 
conditions. DEGS1 assessed some condi-
tions more in detail. For example, after the 
introductory question regarding osteoar-
thritis it is recorded which joints are af-
fected (finger, knee, hips, others).
Osteoarthritis
The results of the first wave of the Europe-
an Health Interview Surveys (EHIS) [41] 
in seven countries show a broad variation 
in the prevalence of self-reported physi-
cian-diagnosed osteoarthritis [3]. It rang-
es from below 5% in Rumania to approx-
imately 25% in Hungary. In addition, the 
results provide evidence that in all coun-
tries, women more often report physician-
diagnosed osteoarthritis than men [3]. In 
all studies, the prevalence of osteoarthri-
tis increases with age. The prevalence of 
self-reported osteoarthritis in Germa-
ny varies between 20 and 25% [42]. The 
overall prevalence in DEGS1 of 20.3% lies 
within this range. A comparison with the 
data from the survey German Health Up-
date 2010 (GEDA10)3 by the RKI shows 
that the lifetime prevalence of osteoar-
thritis in DEGS1 among women aged 18–
79 years is 22.5% and somewhat lower 
than in GEDA10 (25.6%). Among men it 
is slightly higher (18.0%) than in GEDA10 
(17.3%). This can probably be explained 
due to the different survey methods (face-
to-face versus by telephone) or differences 
in sample composition. Population-relat-
ed prevalence estimates based on clinical 
or radiological diagnosis are only avail-
able to a limited extent for Germany. In 
a meta-analysis, Spahn et al. [14] report a 
higher prevalence of radiological osteoar-
thritis of the knee in women (32.6%) than 
in men (24.3%). The higher prevalence 
in DEGS1 can probably be explained by 
2   GNHIES98: Inflammatory joint or spinal disor-
der (for example chronic polyarthritis, rheu-
matoid arthritis, Bekhterev’s disease); DEGS1: 
rheumatoid arthritis (if necessary with expla-
nation “a serious inflammatory joint disorder, 
mostly occurring on both sides and almost 
always including the finger joints”).
3   Own calculations for the 18- to 79 year-old 
age group.
Tab. 3 Lifetime prevalence of osteoporosis by sex, age group and social status—only 
participants of 50 years or older














Low 7.4 11.5 29.9 18.5 65 321
95% CI 3.3–15.6 6.8–18.8 22.0–39.3 14.2–23.7   
Middle 3.5 13.2 22.7 12.0 178 1199
95% CI 2.1–5.7 9.9–17.5 18.0–28.2 10.0–14.4   
High 3.3 12.0 19.7 8.4 41 389
95% CI 1.3–8.1 7.0–19.8 11.3–32.0 6.1–11.6   
 Overall 4.1 12.7 25.2 13.1 284 1909
95% CI 2.7–6.0 10.2–
15.6




Low 4.3 2.8 3.3 3.6 11 312
95% CI 1.3–13.3 0.8–8.9 0.8–11.9 1.7–7.3   
Middle 3.5 2.7 3.5 3.3 46 1066
95% CI 1.9–6.2 1.5–5.0 1.9–6.7 2.3–4.6   
High 1.9 1.9 5.3 2.6 13 559
95% CI 0.5–7.0 0.7–4.9 1.6–16.2 1.3–5.0   
 Overall 3.3 2.6 3.8 3.2 70 1937




Low 5.7 7.7 20.6 11.9 76 633
95% CI 2.9–10.9 4.8–12.0 15.2–27.2 9.4–15.1   
Middle 3.5 8.4 13.9 7.9 224 2265
95% CI 2.3–5.1 6.4–10.9 11.0–17.3 6.7–9.3   
High 2.6 5.7 10.4 5.0 54 948
95% CI 1.2–5.4 3.6–8.8 6.3–16.7 3.7–6.9   
 Overall 3.8 7.6 16.1 8.5 354 3846




the fact that typical signs of osteoarthri-
tis are often already visible in X-ray imag-
es, without the person affected experienc-
ing any pain [16].
Heavy, physical, job-related load is as-
sociated with the origin of osteoarthritis 
[42]. The higher prevalence of osteoar-
thritis among women of low educational 
status could be due to working conditions. 
In addition, the known higher prevalence 
of obesity among persons of low social 
status [43] may plays also a role in the fre-
quency of osteoarthritis in this popula-
tion group.
Rheumatoid arthritis (RA)
Different estimates on the prevalence 
of RA result from the formulation of 
the question. They differ if the question 
quotes arthritis in general or “rheumatoid 
arthritis” in particular. For this reason, the 
question in DEGS1 explicitly referred to 
“rheumatoid arthritis”; nevertheless, mis-
classifications by the participants cannot 
be excluded. In the German Rheumatoid 
Arthritis Population Survey (GRAPS) 
conducted by the German Rheumatism 
Research Centre (“Deutsches Rheuma-
Forschungszentrum”, DRFZ) 70% of peo-
ple with a clinically confirmed RA report-
ed correctly a RA in the written survey. 
People with other joint disorders however, 
very frequently incorrectly report a RA di-
agnosis [44]. It can therefore be assumed 
that in DEGS1 the prevalence for chronic 
inflammatory and rheumatic joint condi-
tions is overestimated on the basis of the 
formulation of the question.
For the age group 18–44 years the esti-
mated prevalence for RA in DEGS1 corre-
sponds with the estimates for self-report-
ed RA from GRAPS and is lower for the 
other age groups [45]. In GEDA10, 7.1% of 
women and 4.1% of men report that they 
had at some point been diagnosed by a 
doctor as having “arthritis, rheumatoid 
arthritis or chronic polyarthritis” (life-
time prevalence). Overall both the esti-
mates from GEDA10 and DEGS1 are sig-
nificantly higher than the estimates from 
population-related surveys on RA preva-
lence with specific information regarding 
the diagnosis [3, 46, 47]. Based on clinical 
classification criteria of RA, Wasmus et al. 
[48] estimate the prevalence of RA in Ger-
many from 0.5 to 0.8% in the adult pop-
ulation. The prevalence based on clinical 
criteria is lower than the prevalence esti-
mates based on self-reports. Misclassifica-
tions by the participants are possibly the 
explanation for this.
A series of studies shows the relation-
ship between RA and low social status [49, 
50]. The higher prevalences for men seen 
in DEGS1 correspond to these results.
Osteoporosis
Similar to osteoarthritis and RA, the prev-
alence estimates for osteoporosis differ by 
type and source of the data and the com-
position of the study population. In addi-
tion, international prevalence estimates 
regarding osteoporosis are often based 
on measurement of bone density. This 
was not possible within DEGS1. Because 
of the different method used, prevalence 
estimates based on measurements are not 
comparable with those of DEGS1.
The age and sex differences in the 
prevalence of osteoporosis in DEGS1 are 
comparable to various studies in Ger-
many. In the Augsburg MONICA Study, 
Meisinger et al. [51] describe the lifetime 
prevalence of self-reported osteoporosis 
in the 25- to 74-year-old age group as 7% 
for women and 1% for men based on the 
1994/1995 survey. Using claims data from 
the “Gmünder Ersatzkasse” (diagnoses 
and prescriptions) Häussler et al. [52] re-
port an osteoporosis prevalence of 23.3% 
among women and 7.1% in men in the age 
group 50–64 years and 46.7% in women 
and 11.4% for men among 65–74 year olds.
Details regarding physician-diagnosed 
osteoporosis are available from various 
other surveys conducted by the RKI. In 
their 2003 telephone survey the lifetime 
prevalence among women aged 45 and 
older was 14.2% [11],4 in GEDA10 (partic-
ipants aged 50 and older) it was 15.7% in 
women and 4.1% among men. The preva-
lence increased significantly among wom-
en with age; from 7.6% among 50–59 year 
olds to 23.7% for 70–79 year olds. No such 
age-dependency was observed in men. In 
the EVOS Study the prevalence of clini-
cally diagnosed, manifest osteoporosis is 
4   Osteoporosis was only surveyed among 
women in this study.
13.0% among 60- to 69-year-old women 
and 22.8% in 70–79 year olds, whilst in 
men it is 5.1 and 5.8% respectively [53]. In 
spite of different methods, the results es-
tablished as part of DEGS1 match these re-
sults.
In national comparisons it must be 
considered that in recent years in Germa-
ny the guideline recommendations and 
accounting modalities have changed [29]. 
Consequently consideration of the sur-
vey period is of particular significance 
with regard to comparisons. Among 50- 
to 65-year-old women there has been a 
decrease in osteoporosis rates according 
to DEGS1 when compared to GNHIES98. 
This can possibly be attributed to the fact 
that bone density measurements are con-
ducted less frequently among young-
er people in line with current guideline 
recommendations, which means diagno-
ses are not forthcoming or are not made 
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